NEOGENOMICS INC — Director's Dealing 2015

Nov 27, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2015-11-25

Reporting Person: JONES STEVEN C (Executive VP of Finance)
Reporting Person: ASPEN SELECT HEALTHCARE LP (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-11-25	Common Stock	S	212745	$8.095	Disposed	0	Indirect
2015-11-25	Common Stock	S	137255	$8.095	Disposed	3362745	Indirect
2015-11-27	Common Stock	S	35000	$8.059	Disposed	3327745	Indirect
2015-11-27	Common Stock	G	25000	$8.05	Disposed	286251	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	50476	Indirect
Common Stock	32157	Indirect
Common Stock	190000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants (Right to Buy)	$1.50	2017-05-03	Common Stock (0)	450000	Direct
Stock Option (Right to Buy)	$4.78	2020-05-04	Common Stock (0)	225000	Direct

Footnotes

F1: An investment partnership entity controlled by Steven Jones. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his pecuniary interests therein.

F2: Aspen Select Healthcare, LP is a private investment fund. Medical
Venture Partners, LLC is the sole general partner of Aspen Select Healthcare, LP, and Mr. Jones is a Managing Member of Medical Venture Partners, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein.

F3: Closing stock price on November 25, 2015

F4: Such warrants were issued in connection with a consulting agreement, dated 5/3/2010.

F5: On May 4, 2015, Mr. Jones was granted 225,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.